Scrapie, a spongiform encephalopathy of sheep and goats, is caused by a poorly understood transmissible agent in which no nucleic acid has been conclusively identified. Biochemical characterization of agent derived from animal tissues has not been precise because of the tenacious association of the agent with tissue components. As an approach toward obtaining homogeneous preparations of agent generated in vitro, we cloned scrapie-infected neuroblastoma cells. By frequency analysis, nearly every cell in expanded cultures contained scrapie agent. We also analyzed cell-dose infectivity relationships and developed a standard curve which allowed various cultures to be compared. Since a proteinase K (PK)-resistant form of a protein designated prion protein (PrP) has been found in partially purified preparations of scrapie agent from infected animal spleens and brains, we sought to identify this protein in cell cultures. No PK-resistant PrP was found in infected or uninfected cultures, although the PK-sensitive PrP was readily detected. These results suggested that PK-resistant PrP may not be an essential component of the infectious scrapie agent.
Scrapie agent derived from animal tissues has not been purified to sufficient homogeneity to allow adequate biochemical characterization. However, several properties, particularly unusual resistance to inactivation by radiation, have been attributed to the agent and distinguish it from most (2, 8, 14) , but not all, viruses (24) . The only macromolecular structures consistently detected in partially purified preparations from brains of infected animals are fibrils known as scrapie-associated fibrils (9, 17) or prion rods (22) which consist primarily of a proteinase K (PK)-resistant protein called prion protein (PrP) (3, 11, 16) or scrapieassociated fibril protein (9, 11) . Samples that contain the protein also have infectivity but no (2) or little detectable nucleic acid (19a) . These associations have led several investigators to propose that infectivity is transmitted by the fibrils (9, 18, 27) or the PK-resistant form of PrP itself (3, 20) . In contrast, other investigators suggest that the protein may accumulate as a by-product of central nervous system degeneration (4) .
Tissue cultures supporting scrapie agent replication should be useful in characterizing the agent and distinguishing it from associated pathogenic by-products present in in vivo tissue sources. However, the low and unpredictable levels of infectivity present in previously described scrapieinfected cultures have hampered the usefulness of tissue cultures in this regard (6, 7, 15, 25, 29) . We have previously described in vitro infection of mouse neuroblastoma cells with scrapie agent and determined that the frequency of infected cells in these cultures was approximately 1% (23) . In the present study, infected cells were cloned and expanded into cultures in which most of the cells replicated scrapie agent. These cultures had infectivity titers 100-fold higher than those of uncloned cultures available before and were used to study the biosynthesis and relationship of PrP to infectivity. 18 ,000 x g for 5 min at room temperature. The supernatant was recovered, and a weight of NaCl equal to the original weight of the tissue was added. This suspension was left overnight at 4°C and then was centrifuged at 27,000 x g at 4°C for 1 h. The pellet was suspended in a small volume of 0.01 M Tris hydrochloride (pH 7.5) and then treated with PK (0.1 p.g/100 mg of original tissue) for 30 min at 37°C. The suspension was made 2 mM PMSF and left for 15 min on ice to inactivate the PK. Ice-cold ethanol (2.5 volumes) was added for 2 h at -20°C followed by centrifugation at 5,000 x g for 10 min at 4°C. Proteins were dissolved by boiling for 5 min in 4% SDS. An equal volume of 2x sample buffer (13) Proteins were separated on 12.5% polyacrylamide gels (13) and transferred to nitrocellulose by using a Trans-blot apparatus (Bio-Rad) at 35 V for 2 h in phosphate buffer (1) PK sensitivity of PrP. A characteristic feature which distinguishes most of the PrP isolated from scrapie-infected brain from that of normal brain is its partial resistance to PK digestion under certain conditions (19) . To test whether metabolically labeled PrP in the scrapie-infected neuroblastoma cells shared this characteristic, detergent-treated homogenates were prepared and treated with PK under conditions similar to those used to detect PK-resistant PrP in whole scrapie-infected brain homogenates by Western blot (26) . Although PrP bands were clearly visible in untreated samples, none remained after treatment with PK at concentrations equal to and 10-fold lower than the concentration (50 ,ug/ml) to which scrapie-infected brain PrP was partially resistant (Fig. 3) . Although not visible in the figure, a weak band at 27 kDa was generated by the 5-,ug/ml PK treatment. However, this band was also observed in PK-treated preparations of normal neuroblastoma cells and scrapie-negative subclones, and its immunoprecipitation was not inhibited by the unlabeled PrP peptide. Thus, this band was neither scrapie nor PrP specific. Similar results were also obtained when PrP-containing membranes were partially purified from metabolically labeled, scrapie-infected cells before PK treatment. Clone 29-301 (a scrapie-positive subclone of 29-161) cells were homogenized, fractionated by differential centrifugation into pellets at 10,000 x g and 100,000 x g, and treated with PK by methods described for the detection of PrP in brain tissue by Western blot (19) . PrP bands identical to those shown in Fig. 2 and 3 were immunoprecipitated from both the pellets, but again no PK-resistant PrP bands remained after treatment with either the prescribed PK concentration (100 ,ug/ml) or with a 20-fold-lower concentration (data not shown). Thus, under a variety of conditions similar to those appropriate for observing PK-resistant PrP from scrapie-infected brain tissue, the metabolically labeled PrP in scrapie-infected neuroblastoma cells appeared completely sensitive to PK. The possibility remains, however, that a small portion of the total PrP in these cells was PK resistant but below the level of detection.
Analysis of scrapie-infected and uninfected clones by Western blotting. Since we were unable to detect a PK-resistant form of PrP by immunoprecipitation, we sought to do so by using Western blotting. Aliquots of four infected and three uninfected clones prepared by using techniques appropriate for detecting the protein in spleen and brain were analyzed. No cell-associated PrP was detected either before (data not shown) or after PK digestion (Fig. 4) . We also analyzed spleen and neuroblastoma cell clone extracts prepared by the procedure of Kascsak (12) and obtained similar results (data not shown). An additional method has been described recently (5 (23) . However, more highly titered cultures seemed necessary. In this report, we describe cloning of scrapie-infected neuroblastoma cells which gave cultures with markedly improved scrapie titers and high frequencies of infected cells. We also established a cell-dose infectivity curve that allows the relative infectivities of various clones to be compared.
Since the relationship of PrP to infectivity is a significant and controversial issue, we used the infected neuroblastoma cell clones to study this problem. Two forms of PrP are thought to exist, a form found in both normal and infected tissues and a different form found only in infected tissues. The sole criterion for distinguishing between the two forms is the PK resistance of the PrP found in sick animals. It is not known how the disease process itself influences the formation of the PK-resistant form. Some investigators have proposed that PK-resistant PrP could merely be a consequence of the lesions of scrapie (4) rather than a necessary component of the infectious agent (3, 9, 18, 20) . If PKresistant PrP arises as a consequence of tissue lesions and the pathogenesis of the disease, there would be little reason to believe that PK-resistant PrP would accumulate in in vitro-infected cells. Although PrP was readily detected in scrapie-infected and uninfected neuroblastoma cells by radioimmunoprecipitation, none was PK resistant. Furthermore, there was no quantitative or qualitative difference in the PrP that would distinguish infected from uninfected clones. By Western blot, neither form of PrP was detected. Thus, our results are consistent with the hypothesis that a PK-resistant form of PrP is not necessary for infectivity.
If the infectious agent of scrapie does not directly induce the formation of the PK-resistant PrP, how does it arise? The PK-resistant form of PrP could arise in vivo because of alteration of the endogenous PK-sensitive PrP by changes in physiological conditions such as pH, salt concentration, and the action of cellular enzymes released as cells degenerate. Its accumulation to detectable levels in vivo could occur over a period of several weeks. In addition, the protein in diseased animals might contribute to its own formation by forming insoluble complexes under the influence of abnormal physiological conditions much as immunoglobulin and other proteins do in certain amyloid diseases (G. G. Glenner, review, N. Engl. J. Med. 302:1283-1292, 1333-1343, 1980) . Thus the correlation of PrP with infectious agent may simply represent incidental copurification of agent and PrP. The evidence for the inseparability of scrapie infectivity and PrP, though tantalizing, is still circumstantial (3, 9, 18, 20) .
Additional studies will be necessary to prove an association of PK-resistant PrP and infectivity if such an association actually exists.
